Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT02327221
Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2014
Completion: Nov 30, 2016